Ongoing Clinical Trials
Are you interested in participating in a clinical trial?
View all available UNC research for Kidney, Liver, and Transplant at Research for Me (UNC based website)
-
- APOL1 Long-term Kidney Transplantation Outcomes Network
- Purpose: The APOLLO study is being done in an attempt to improve outcomes after kidney transplantation and to improve the safety of living kidney donation based upon variation in the apolipoprotein L1 gene (APOL1). Variation in APOL1 can cause kidney disease. African Americans, Afro-Caribbeans, Hispanic Blacks, and Africans are more likely to have the APOL1 gene variants that cause kidney disease. APOLLO will test DNA from kidney donors and recipients of kidney transplants for APOL1 to determine effects on kidney transplant-related outcomes.
- ClinicalTrials.gov ID: NCT03615235
- Sponsor: Wake Forest University Health Sciences
- Status: Recruiting
- APOL1 Long-term Kidney Transplantation Outcomes Network